T1	Procedure 463 471	dialysis
T2	Procedure 550 580	international normalized ratio
T3	Procedure 691 699	dialysis
T4	Procedure 821 831	creatinine
T5	Procedure 832 841	elevation
T6	Procedure 935 945	creatinine
T7	Procedure 1070 1072	mg
T8	Procedure 1093 1103	prevention
T9	Procedure 1669 1676	primary
T10	Procedure 1722 1724	mg
T11	Procedure 1752 1754	mg
T12	Procedure 1781 1783	mg
T13	Procedure 1813 1815	mg
T14	Procedure 1866 1886	creatinine clearance
T15	Procedure 1866 1876	creatinine
T16	Procedure 1978 1980	mg
T17	Procedure 2070 2086	serum creatinine
T18	Procedure 2076 2086	creatinine
T19	Procedure 2092 2094	mg
T20	Procedure 454 471	those on dialysis
T21	Procedure 528 591	warfarin with careful international normalized ratio monitoring
T22	Procedure 682 699	those on dialysis
T23	Procedure 810 841	her modest creatinine elevation
T24	Procedure 922 945	decisions on creatinine
T25	Procedure 1038 1072	anticoagulation with apixaban 5 mg
T26	Procedure 1089 1113	the prevention of stroke
T27	Procedure 1669 1685	primary efficacy
T28	Procedure 1690 1724	safety outcomes for 150 and 110 mg
T29	Procedure 1749 1766	15 mg rivaroxaban
T30	Procedure 1779 1792	5 mg apixaban
T31	Procedure 1810 1815	30 mg
T32	Procedure 1856 1886	estimated creatinine clearance
T33	Procedure 1965 1980	Apixaban 2.5 mg
T34	Disease_disorder 98 100	AF
T35	Disease_disorder 399 415	renal impairment
T36	Disease_disorder 405 415	impairment
T37	Disease_disorder 640 642	AF
T38	Disease_disorder 654 670	renal impairment
T39	Disease_disorder 660 670	impairment
T40	Disease_disorder 780 782	AF
T41	Disease_disorder 964 970	stroke
T42	Disease_disorder 1107 1113	stroke
T43	Disease_disorder 1127 1135	embolism
T44	Disease_disorder 1240 1248	bleeding
T45	Disease_disorder 1516 1538	chronic kidney disease
T46	Disease_disorder 1524 1538	kidney disease
T47	Disease_disorder 1531 1538	disease
T48	Disease_disorder 1581 1600	atrial fibrillation
T49	Disease_disorder 1588 1600	fibrillation
T50	Disease_disorder 1660 1663	CIs
T51	Disease_disorder 63 100	those of warfarin in patients with AF
T52	Disease_disorder 366 415	warfarin in patients with severe renal impairment
T53	Disease_disorder 626 642	patients with AF
T54	Disease_disorder 647 670	severe renal impairment
T55	Disease_disorder 765 800	a patient with AF with moderate CKD
T56	Disease_disorder 953 975	Her annual stroke risk
T57	Disease_disorder 1089 1113	the prevention of stroke
T58	Disease_disorder 1118 1135	systemic embolism
T59	Disease_disorder 1202 1248	apixaban because of the lower risk of bleeding
T60	Disease_disorder 1465 1538	warfarin in the subgroup of patients with moderate chronic kidney disease
T61	Disease_disorder 1562 1600	clinical trials in atrial fibrillation
T62	Sign_symptom 207 221	renal function
T63	Sign_symptom 443 444	m
T64	Sign_symptom 1127 1135	embolism
T65	Sign_symptom 1177 1191	renal function
T66	Sign_symptom 1638 1648	confidence
T67	Sign_symptom 1923 1924	m
T68	Sign_symptom 184 221	frequent monitoring of renal function
T69	Sign_symptom 1118 1135	systemic embolism
T70	Sign_symptom 1142 1191	a plan for close monitoring of her renal function
T71	Sign_symptom 1634 1658	95% confidence intervals
T72	Anatomical_structure 207 212	renal
T73	Anatomical_structure 262 267	scale
T74	Anatomical_structure 399 404	renal
T75	Anatomical_structure 654 659	renal
T76	Anatomical_structure 1177 1182	renal
T77	Anatomical_structure 1434 1438	oral
T78	Anatomical_structure 1524 1530	kidney
T79	Anatomical_structure 1581 1587	atrial
